HEALWELL AI Boosts Research with BioPharma Acquisition
Company Announcements

HEALWELL AI Boosts Research with BioPharma Acquisition

MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) has released an update.

HEALWELL AI is set to enhance its clinical research capabilities through the strategic acquisition of BioPharma Services Inc., a prominent Canadian Contract Research Organization (CRO) specializing in bioequivalence and early-stage clinical trials. By integrating BioPharma’s expertise with its own AI technologies and vast patient databases, HEALWELL aims to accelerate and improve patient-centered clinical research. The deal includes an initial $11.9 million in cash and shares with potential additional performance-based payments, bolstering HEALWELL’s projected annual revenue to over $65 million.

For further insights into TSE:AIDX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskWELL Health and HEALWELL AI Expand Clinical Trials
TipRanks Canadian Auto-Generated NewsdeskHEALWELL AI Invests in Abstractive Health Partnership
TipRanks Canadian Auto-Generated NewsdeskBioPharma Services Expands into Late-Stage Trials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App